Opinion

Video

Primary Treatment Goals for Patients With IgAN

Key Takeaways

  • Biomarkers, including genetic mutations and protein expressions, are vital for predicting disease progression and treatment response.
  • Advanced diagnostic techniques are essential for identifying molecular and cellular indicators that inform patient prognosis.
SHOW MORE

Panelists discuss how the primary treatment goals for patients with IgA nephropathy evolve based on the stage of the disease, emphasizing the importance of tailoring strategies to individual patient needs.

  1. What are the primary treatment goals for patients with IgA nephropathy, and how do they evolve based on the stage of the disease?
Related Videos
New Buprenorphine Label Allows Physician-Informed Treatment of Opioid Use Disorder, with Bobby Mukkamala, MD
Jonathan Stine, MD, MSc | Credit: AASLD
Christina Druskovich: A Mentorship Opportunity with the Society for Pediatric Dermatology
Evaluating the Medtronic 780G System in Type 2 Diabetes | Image Credit: HCPLive
Understanding Omnipod 5 AID and SECURE-T2D | Image Credit: HCPLive
© 2025 MJH Life Sciences

All rights reserved.